Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Psychological interventions for postnatal depression - randomised controlled trial and economic evaluation
Source of recordUK Trials
ISRCTNISRCTN92195776
Date ISRCTN assigned25/04/2003
Local reference number(s)HTA 99/33/51
Public titlePsychological interventions for postnatal depression - randomised controlled trial and economic evaluation
Scientific title
AcronymPONDER
Disease/condition/study domainMental and behavioural disorders: Depression, anxiety, neuroses; Pregnancy and childbirth: Childbirth
Study hypothesisThe central aim of the study is to assess the costs, effectiveness and broad impact of screening for postnatal depression alongside two counselling interventions, non-directive counselling and cognitive behavioural counselling, delivered by health visitors in their usual clinical setting. Screened women at risk of depression will be interviewed to assess symptom severity. The study will assess effectiveness according to severity, history and duration of depression. The design will reflect the practicalities of primary care service delivery and will ensure that a wide range of effects is identified. In addition, the trial will examine an important practical question, with no loss of statistical power, on the efficiency and value of face-to-face screening by health visitors, compared with postnatal screening.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration.
Countries of trialUnited Kingdom
Participants - inclusion criteriaWomen with live babies who will remain with their GP for 4 months
Participants - exclusion criteriaUnable to give informed consent
Patient information material
Anticipated start date01/04/2003
Anticipated end date31/03/2006
Status of trialCompleted
Target number of participants4000 women from 93 General Practices
InterventionsNon-directive counselling (NDC) v Cognitive Behavioural-type Counselling (CBC) delivered by Health Visitors in their usual clinical setting v standard care
Primary outcome measure(s)The efficiency and value of face-to-face screening by health visitors, compared with postnatal screening. Women's postal questionnaires, casenotes and activity data will be used to monitor changes in symptoms, health outcomes, hospital admissions, NHS service use, family well-being and infant progress to eighteen months
Secondary outcome measure(s)Not provided at time of registration.
Sources of fundingNIHR Health Technology Assessment Programme - HTA (UK)
Sponsor nameDepartment of Health (UK)
Sponsor detailsQuarry House
Quarry Hill
Leeds
United Kingdom
LS2 7UE
Sponsor emailSheila.Greener@doh.gsi.gov.uk
Sponsor websitehttp://www.dh.gov.uk/en/index.htm
Contact nameMs Jane Morrell
Contact detailsSchool of Health & Related Research
University of Sheffield
12 Victoria Road
Broomhall
Sheffield
United Kingdom
S10 2DL
Contact telephone+44 (0)114 249 2500
Contact fax+44 (0)114 272 4095
Contact emailmorrello@blueyonder.co.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN92195776
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central